乳児栄養におけるオリゴ糖の市場規模：形態別、用途別、タイプ別、地域別、2026-2032年

乳児栄養におけるオリゴ糖市場の評価-2026-2032

基本的な栄養を提供するだけでなく、その他の健康特典を提供する機能性食品に対する両親の志向が高まっています。オリゴ糖を強化した乳児用調製粉乳は、この新たな動向に完璧に適合し、乳児向けに特別に調整された機能性食品の選択肢を提示します。このように、機能性食品の採用が増加しているため、市場規模は2024年に2億3,565万米ドルを突破し、2032年には 4億785万米ドルの評価額に達します。

乳児用調製粉乳のメーカーは、母乳の健康上の利点を模倣し、調製粉乳の栄養含有量を高めるために、製品にオリゴ糖を徐々に組み込んでいます。この新たなパターンは、母乳に最も類似した代替品を乳児に与えたいと願う両親のニーズに応えるものです。このように、製品におけるオリゴ糖の高い普及率が、2026年から2032年までのCAGR 10.2%での市場の成長を可能にしています。

乳児栄養市場におけるオリゴ糖：定義/概要

オリゴ糖は小さな炭水化物分子であり、デンプンのような複雑な炭水化物に比べて長さが短いです。オリゴ糖は、脂肪と乳糖に次いで、母乳中に3番目に多く含まれる固形成分です。オリゴ糖は有益な細菌の重要な食物源として働き、乳児の健康な腸内細菌叢を育みます。母乳に見られる健康上の利点を再現するために、オリゴ糖を製品に配合するメーカーが増えています。さらに、オリゴ糖にはヒトミルクオリゴ糖、三糖類、ガラクトオリゴ糖があります。

人乳オリゴ糖は、母乳栄養児の大腸内細菌叢におけるビフィズス菌の個体数を増加させる。この増加は、潜在的に有害な細菌数の顕著な減少と相まって、オリゴ糖のビフィズス形成特性に起因しています。人乳オリゴ糖は母乳栄養児の腸内細菌叢に寄与するだけでなく、今やオリゴ糖は上皮表面への細菌の接着を強力に阻害する役割も果たしています。

将来的には、母乳に近い新世代のオリゴ糖が開発される可能性があります。将来的にオリゴ糖の生産が高度化すれば、費用対効果が高くなり、入手しやすくなります。遺伝、腸内細菌叢の構成、アレルギーの可能性などの要因を考慮し、個々の赤ちゃんの要求に合わせてオリゴ糖を特別にブレンドした乳児用調製粉乳が登場します。

オリゴ糖の多機能性が乳児栄養市場におけるオリゴ糖の成長をどのように促進しているか？

オリゴ糖の構造的多様性、量、多機能性が乳児栄養におけるオリゴ糖の需要を牽引しています。オリゴ糖は、ヒトの母乳中に天然に存在する多機能糖鎖です。オリゴ糖はプレバイオティクスの役割を果たし、腸内に存在する善玉菌に栄養を与えます。善玉菌としてのオリゴ糖のサポートは、腸内細菌叢内の調和のとれたバランスを育み、効率的な消化と免疫機能の強化に不可欠です。オリゴ糖は、有益な微生物に良好な環境を提供し、腸の健康に貢献し、多面的な利点を提供し、消化を超えて拡張します。

オリゴ糖はプレバイオティクス作用により、有益な腸内細菌の増殖を促進し、免疫系を強化します。オリゴ糖は免疫系を強化することで病気を減らし、一般的な健康と幸福感を向上させる。オリゴ糖はアレルギーを軽減し、マウスの妊娠中に特定の難消化性オリゴ糖は、子孫のアレルギー性喘息症状の軽減につながりました。

三糖類は他の炭水化物と同様に、体内でグルコースに分解され、細胞エネルギーの一次燃料源となります。三糖類は単糖類のような単糖類と区別され、消化のペースがやや遅いため、より緩やかで持続的なエネルギー放出をもたらします。特定の三糖類は、体内で明確な役割を果たします。例えば、グルコースの三糖類であるマルトトリオースは、グリコーゲンの貯蔵に貢献し、必要に応じてエネルギーを貯蔵・放出する身体のメカニズムを構成しています。

二糖類は、体にとって簡単にアクセスできるエネルギー源として機能します。摂取すると、消化酵素によって単糖成分に分解され、小腸で容易に吸収されて全身の細胞に分配されます。この迅速な吸収により、さまざまな身体機能をサポートするエネルギーが素早く供給されます。

乳幼児栄養市場におけるオリゴ糖の成長を妨げている保護者の認識不足とは？

現在の研究にもかかわらず、新生児の健康に対する特定のオリゴ糖の長期的な影響はよく理解されていないです。特定のヘルスケア・プロバイダーや親は、決定的な長期データがないため、これらの処方を採用することをためらうかもしれないです。すべての親が乳児用調製粉乳に含まれるオリゴ糖の利点を知っているわけではないです。このような理解不足は、特定の化学物質に関する潜在的な誤解とともに、市場に広く受け入れられるための障壁となる可能性があります。

規制機関は、乳児用調製粉乳に含まれるオリゴ糖の種類と許容量について基準を設けています。厳しい規制は安全性と有効性の要件を確保するために必要であるが、意図せずして技術革新と新規オリゴ糖の市場導入を阻害する可能性があります。その結果、この規制の枠組みは、製品の安全性を保証することと、乳児栄養の進歩を促進することの間で、難しいバランスを取ることになります。

乳児用調製粉乳をオリゴ糖含有粉乳に切り替えた乳児は、特に移行が緩やかでない場合、腹部膨満感やガスなどの消化器系の不快感を経験する可能性があります。この移行期間は、潜在的な不快感を避けるために、オリゴ糖強化ミルクを慎重に導入することの重要性を強調しています。

有用ではあるが、粉ミルクに添加されるオリゴ糖は、母乳に自然に含まれるオリゴ糖とは構造的に異なります。この構造の違いから、粉ミルクと母乳の全体的な同等性に疑問を持つ人もいるかもしれないです。オリゴ糖の添加は栄養学的に粉ミルクを改善するが、顧客の信頼を維持するためには、認識される相違を特定し、是正することが重要です。

目次

第1章 乳児栄養におけるオリゴ糖の世界市場導入

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 乳児栄養におけるオリゴ糖の世界市場、展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 乳児栄養におけるオリゴ糖の世界市場：形態別

• 概要
• 粉末
• 液体

第6章 乳児栄養におけるオリゴ糖の世界市場：用途別

• 概要
• 食品
• 健康食品
• 飲料
• 医薬品

第7章 乳児栄養におけるオリゴ糖の世界市場、タイプ別

• 概要
• ガラクトオリゴ糖
• 人乳オリゴ糖
• フラクトオリゴ糖

第8章 乳児栄養におけるオリゴ糖の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東

第9章 乳児栄養におけるオリゴ糖の世界市場：競合情勢別

• 概要
• 各社の市場ランキング
• 主な開発戦略

第10章 企業プロファイル

• Nissin Sugar Co. Ltd.
• Yakult Pharmaceutical Industry Co., Ltd.
• Kerry Group plc
• Taiwan Fructose
• Dupont nutrition & health
• Royal FrieslandCampina N.V.
• Abbot
• Ingredion
• Biosynth Carbosynth.
• Dextra Laboratories Ltd.
• Inbiose NV
• Jennewein Biotechnologie GmbH
• Tereos
• Zuchem

第10章 付録

• 関連調査

Oligosaccharides in Infant Nutrition Market Valuation - 2026-2032

The growing inclination among parents towards functional foods, which go beyond providing basic nutrition by offering additional health benefits. Infant formula enriched with oligosaccharides perfectly fits into this emerging trend, presenting a functional food choice tailored specifically for infants. Thus, the increasing adoption of functional foods is driving market size to surpass USD 235.65 Million in 2024 to reach the valuation of USD 407.85 Million by 2032.

Manufacturers of infant formula are progressively integrating oligosaccharides into their products to emulate the health advantages of breast milk and elevate the nutritional content of their formulas. This emerging pattern addresses the needs of parents who aspire to offer their infants the most analogous substitute to breast milk available. Thus, the high enactment of oligosaccharides in products is enabling the market to grow at a CAGR of 10.2% from 2026 to 2032.

Oligosaccharide in Infant Nutrition Market: Definition/ Overview

Oligosaccharides are small carbohydrate molecules, shorter in length compared to complex carbohydrates such as starches. Oligosaccharides rank as the third most prevalent solid component in breast milk, following fats and lactose. They act as a vital food source for beneficial bacteria, fostering a healthy gut microbiome in infants. Manufacturers are increasingly incorporating oligosaccharides into their products to replicate the health advantages found in breast milk. In addition, there are types of oligosaccharides human milk oligosaccharide, trisaccharide, and Galactooligosaccharides.

The human milk oligosaccharides lead to a rise in the population of bifidobacteria in the colonic flora of breastfed infants. This increase is coupled with a notable decrease in the number of potentially harmful bacteria, attributed to the bifidogenic properties of oligosaccharides. Human milk oligosaccharides not only contribute to intestinal flora in breastfed infants but now oligosaccharides also serve as a potent inhibitor of bacterial adhesion to epithelial surfaces.

In the future, it is likely to develop a new generation of oligosaccharides that closely resemble breast milk. The advanced production of oligosaccharide in the future can make it cost-effective, and increase its accessibility. The emergence of personalized infant formula featuring specific blends of oligosaccharides tailored to individual baby's requirements, taking into account factors such as genetics, gut microbiome composition, and potential allergies.

How the Multifunctionality of Oligosaccharide is Driving the Growth of Oligosaccharide in the Infant Nutrition Market?

The structural diversity, quantity, and multifunctionality of oligosaccharides are driving the demand for oligosaccharides in human infant nutrition. Oligosaccharide is a prominent component in human milk it is a multifunctional glycan, which is naturally present in human milk. Oligosaccharides serve as prebiotics, which nourish the beneficial bacteria residing in the gut. This support of oligosaccharide support as a good bacteria fosters a harmonious balance within the gut microbiome, it is vital for efficient digestion and bolstered immune function. Oligosaccharides provide a favorable environment for beneficial microorganisms, they also contribute to gut health, offer multifaceted benefits, and extend beyond digestion.

Oligosaccharide promote the growth of beneficial gut bacteria, because of its prebiotic action and fortifies the immune system. Oligosaccharides reduce illness by bolstering the immune system and demonstrate to improve general health and well-being. Oligosaccharide reduces the allergy, during pregnancy in mice the specific nondigestible oligosaccharide led to reduced allergic asthma symptoms in the offspring.

Trisaccharides, akin to other carbohydrates, undergo breakdown into glucose within the body, serving as the primary fuel source for cellular energy. Trisaccharides, distinguished from simple sugars like monosaccharides, undergo digestion at a slightly slower pace, resulting in a more gradual and sustained release of energy. Specific trisaccharides fulfill distinct roles within the body. For instance, maltotriose, a glucose trisaccharide, contributes to glycogen storage, which constitutes the body's mechanism for storing and releasing energy as needed.

Disaccharides serve as an easily accessible energy source for the body. Upon ingestion, digestive enzymes break them down into their monosaccharide components, which are readily absorbed by the small intestine and distributed to cells throughout the body. This rapid absorption facilitates quick energy delivery to support a range of bodily functions.

How the Lack of Awareness among the Parents is Hampering the Growth of Oligosaccharides in the Infant Nutrition Market?

Despite current studies, the long-term effects of particular oligosaccharides on newborn health are not well understood. Certain healthcare providers or parents may be hesitant to adopt these formulae due to a lack of conclusive long-term data. Not all parents are aware of the benefits of oligosaccharides in infant formula. This lack of understanding, along with potential misconceptions about certain chemicals, could be a barrier to widespread market acceptance.

Regulatory bodies have created criteria for the permitted types and quantities of oligosaccharides in infant formula. While tight regulations are necessary to ensure safety and efficacy requirements, they can unintentionally stifle innovation and the introduction of novel oligosaccharides to the market. As a result, this regulatory framework strikes a difficult balance between guaranteeing product safety and promoting advances in baby nutrition.

Infants switching to oligosaccharide-containing formula may experience digestive discomfort such as bloating or gas, especially if the transition is not gradual. This transition period emphasizes the significance of introducing oligosaccharide-enriched formulas with caution to avoid potential discomfort.

Although helpful, oligosaccharides added to the formula differ structurally from those found naturally in breast milk. This structural distinction may lead some to question the overall equivalence of formula and breast milk. While oligosaccharide supplementation improves the formula nutritionally, it is critical to identify and rectify any perceived discrepancies to maintain customer trust.

Category-Wise Acumens

How the Increasing Consumer Awareness of Gut Health and the Rise in the Infant Population is Driving the Human Milk Oligosaccharide Segment Growth?

The human milk oligosaccharide segment is substantially growing in the oligosaccharide infant nutrition market and is expected to continue its growth throughout the forecast period. Rising consumer knowledge of the benefits of gut health, as well as increased demand for nutritional supplements, are important drivers driving the human milk oligosaccharide (HMO)) segment in the oligosaccharide infant nutrition market. HMOs, known for their antibacterial and prebiotic qualities, are set to become widespread in a variety of industries, including infant formulae, pharmaceuticals, and functional foods. Population growth, rising mortality rates, and a greater emphasis on health awareness are likely to drive the HMO business ahead.

In addition, the rise in the infant population is contributing to the growth of the human milk oligosaccharide segment. For instance, the current birth rate in 2024 is 17.299 births per 1000 people and 17.464 per 1000 people in 2023. The increasing birth rate is fueling the demand for human milk oligosaccharides. In the United States, the provisional number of births is 3,661,220 in 2022.

The rising prevalence of chronic illnesses such as gastrointestinal disorders, diabetes, high blood pressure, and rickets is driving up demand for functional foods and beverages, boosting growth in the human milk oligosaccharide market. In addition, the infant formula and baby food businesses are expected to grow significantly because of rising demand, increased HMO production, and regulatory approvals. Ongoing research is always revealing new health benefits related to certain HMO configurations. This ongoing research is expected to widen the potential applications of HMOs beyond newborn nutrition, accelerating market growth.

How the Health Benefits Associated with the Oligosaccharide is Fueling the Growth of the Food Segment in the Oligosaccharide in Infant Nutrition Market?

The food segment is significantly showing the growth in the oligosaccharide in the infant nutrition market. The wide range of health advantages associated with functional oligosaccharides is a major reason for their integration into dietary products. These advantages include immunological modulation, intestinal health promotion, enhanced stomach microbial activity, increased calcium absorption, and bone mineral density maintenance, particularly among adolescents.

Furthermore, functional oligosaccharides provide distinct physiological benefits such as being zero or low in calories while performing specific functions such as stimulating the proliferation of beneficial bacteria such as Bifidobacterium, enhancing the body's immune response, preventing dental caries and constipation, and even exhibiting potential anti-tumor properties.

Natural sources of oligosaccharides, such as fructooligosaccharides (FOS) found in fruits and vegetables like onions and bananas, provide an extra impetus for their use in food items. Although these natural oligosaccharides may be difficult for the human body to digest, they are valuable bioactive components that helpful bacteria such as Bifidobacterium can easily consume. This usage promotes a healthy and active gut microbiota, which protects against gastrointestinal illnesses.

How will the Rising Birth Rate in Asia Pacific Drive the Market?

Asia Pacific is substantially growing the oligosaccharide in the infant nutrition market thanks to the increasing awareness of the importance of early childhood nutrition, combined with a comprehension of the favorable function oligosaccharides play in newborn health. As parents grow more health-conscious, they are actively looking for infant feeding solutions that not only meet their fundamental nutritional requirements but also provide additional health benefits.

In response to this trend, there is a shift toward a more holistic approach to infant nutrition, in which parents prioritize products that provide comprehensive nutritional support, such as oligosaccharides, which promote overall health and well-being. This increased understanding emphasizes the significance of early nutritional changes in determining long-term health outcomes for infants.

The growing demand for functional foods in APAC reflects a larger trend toward preventative healthcare and wellness-oriented lifestyles. Parents are looking for child nutrition products that contain oligosaccharides, which they believe are important for immunological health, digestive function, and overall growth and development during infancy.

Healthcare professionals, government organizations, and industry stakeholders use educational campaigns and initiatives to raise awareness about the importance of early childhood nutrition and the benefits of oligosaccharides. By providing parents with knowledge and information, these initiatives help to meet the growing demand for oligosaccharide-enriched infant feeding products in the APAC market.

Competitive Landscape

The competitive landscape for oligosaccharides in infant nutrition is dynamic and evolving. Companies that can successfully navigate these trends through innovation, cost-effectiveness, strategic partnerships, and a focus on sustainability are likely to thrive in this growing market.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players

operating in the oligosaccharides in infant nutrition market include:

• Nissin Sugar Co. Ltd.
• Yakult Pharmaceutical Industry Co., Ltd.
• Kerry Group plc
• Taiwan Fructose
• Dupont nutrition & health
• Royal FrieslandCampina N.V.
• Abbot
• Ingredion
• Biosynth Carbosynth.
• Dextra Laboratories Ltd.
• Inbiose NV
• Jennewein Biotechnologie GmbH
• Tereos
• Zuchem

Key Devlopments

• In February 2019, DuPont Nutrition and Health announced an agreement with Lonza Specialty to manufacture and supply the CARE 4U-FL a Human Milk Oligosaccharide.
• In October 2023, Royal FrieslandCampina N.V. announced its entrance into the world's largest infant milk formula market in China.

Oligosaccharide in Infant Nutrition Market, By Category

• Form:
• Powder
• Liquid
• Application:
• Food
• Health Products
• Drinks
• Medicine
• Type:
• Galactooligosaccharides
• Human Milk Oligosaccharides
• Fructooligosaccharides
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL OLIGOSACCHARIDES IN INFANT NUTRITION MARKET,

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL OLIGOSACCHARIDES IN INFANT NUTRITION MARKET, OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL OLIGOSACCHARIDES IN INFANT NUTRITION MARKET, BY FORM

• 5.1 Overview
• 5.2 Powder
• 5.3 Liquid

6 GLOBAL OLIGOSACCHARIDES IN INFANT NUTRITION MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Food
• 6.3 Health Products
• 6.4 Drinks
• 6.5 Medicine

7 GLOBAL OLIGOSACCHARIDES IN INFANT NUTRITION MARKET, BY TYPE

• 7.1 Overview
• 7.2 Galactooligosaccharides
• 7.3 Human Milk Oligosaccharides
• 7.4 Fructooligosaccharides

8 GLOBAL OLIGOSACCHARIDES IN INFANT NUTRITION MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East

9 GLOBAL OLIGOSACCHARIDES IN INFANT NUTRITION MARKET, BY COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Nissin Sugar Co. Ltd.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Yakult Pharmaceutical Industry Co., Ltd.
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Kerry Group plc
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Taiwan Fructose
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Dupont nutrition & health
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Royal FrieslandCampina N.V.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Abbot
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Ingredion
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Biosynth Carbosynth.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Dextra Laboratories Ltd.
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments
• 10.11 Inbiose NV
  • 10.11.1 Overview
  • 10.11.2 Financial Performance
  • 10.11.3 Product Outlook
  • 10.11.4 Key Developments
• 10.12 Jennewein Biotechnologie GmbH
  • 10.12.1 Overview
  • 10.12.2 Financial Performance
  • 10.12.3 Product Outlook
  • 10.12.4 Key Developments
• 10.13 Tereos
  • 10.13.1 Overview
  • 10.13.2 Financial Performance
  • 10.13.3 Product Outlook
  • 10.13.4 Key Developments
• 10.14 Zuchem
  • 10.14.1 Overview
  • 10.14.2 Financial Performance
  • 10.14.3 Product Outlook
  • 10.14.4 Key Developments

10 Appendix

• 10.1 Related Research